Holen Sie sich die Stockscreener-App
22.81
1.47%
-0.3404
Schlusskurs vom Vortag:
$23.15
Offen:
$23.2
24-Stunden-Volumen:
60,745
Relative Volume:
0.09
Marktkapitalisierung:
$2.80B
Einnahmen:
$1.80B
Nettoeinkommen (Verlust:
$15.62M
KGV:
190.08
EPS:
0.12
Netto-Cashflow:
$118.36M
1W Leistung:
-2.77%
1M Leistung:
-4.12%
6M Leistung:
+7.59%
1J Leistung:
+8.98%
1-Tages-Spanne:
$22.78
$23.53
1-Wochen-Bereich:
$22.80
$24.60
52-Wochen-Spanne:
$18.77
$26.51
Privia Health Group Inc Stock (PRVA) Company Profile
Firmenname
Privia Health Group Inc
Sektor
Branche
Telefon
571-366-8850
Adresse
950 N. GLEBE RD., SUITE 700, ARLINGTON
Vergleichen Sie PRVA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRVA
Privia Health Group Inc
|
22.78 | 2.85B | 1.80B | 15.62M | 118.36M | 0.12 |
|
VEEV
Veeva Systems Inc
|
240.91 | 39.64B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
67.48 | 12.16B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
43.66 | 8.23B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
94.18 | 8.42B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
37.97 | 7.05B | 11.99B | 24.18M | 234.31M | 0.2956 |
Privia Health Group Inc Stock (PRVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Outperform |
| 2025-01-10 | Eingeleitet | Needham | Buy |
| 2024-12-16 | Eingeleitet | Macquarie | Outperform |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-04-22 | Eingeleitet | Citigroup | Buy |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-02-26 | Fortgesetzt | Jefferies | Buy |
| 2024-02-22 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-12-06 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-06-13 | Eingeleitet | Evercore ISI | Outperform |
| 2023-04-12 | Eingeleitet | Stephens | Overweight |
| 2023-03-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-02-03 | Eingeleitet | Goldman | Buy |
| 2022-12-09 | Eingeleitet | Stifel | Buy |
| 2022-12-08 | Eingeleitet | UBS | Buy |
| 2022-09-07 | Fortgesetzt | Truist | Buy |
| 2022-05-03 | Eingeleitet | BofA Securities | Buy |
| 2022-04-28 | Eingeleitet | BTIG Research | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-30 | Eingeleitet | Guggenheim | Buy |
| 2022-02-22 | Hochstufung | Cowen | Market Perform → Outperform |
| 2022-01-03 | Eingeleitet | Jefferies | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-05-24 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-05-24 | Eingeleitet | Credit Suisse | Outperform |
| 2021-05-24 | Eingeleitet | JP Morgan | Overweight |
| 2021-05-24 | Eingeleitet | Piper Sandler | Overweight |
| 2021-05-24 | Eingeleitet | Truist | Buy |
| 2021-05-24 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Privia Health Group Inc Aktie (PRVA) Neueste Nachrichten
Will Privia Health Group Inc. stock recover faster than peers2025 Trading Recap & Consistent Profit Focused Trading Strategies - ulpravda.ru
Privia Health stock rating initiated at Outperform by RBC Capital - Investing.com
Can Privia Health Group Inc. stock attract ESG capital inflowsJuly 2025 Trends & Weekly Top Performers Watchlists - ulpravda.ru
Citizens reiterates Market Outperform rating on Privia Health stock By Investing.com - Investing.com Canada
Citizens reiterates Market Outperform rating on Privia Health stock - Investing.com
Privia Health Group, Inc. (PRVA) Stock Analysis: Riding A 29.51% Potential Upside Wave - DirectorsTalk Interviews
Evolent Health (EVH) sells ACO unit, strengthens balance sheet - MSN
Privia Health Group Inc Stock Analysis and ForecastLow Beta Stocks & Free Superior Trading Gains - earlytimes.in
Privia Health Group, Inc.'s (NASDAQ:PRVA) Stock Has Shown A Decent Performance: Have Financials A Role To Play? - 富途牛牛
Privia Health Group, Inc. $PRVA Shares Sold by Corient Private Wealth LLC - Defense World
The Zacks Analyst Blog Highlights Hims & Hers Health, Biotricity and Privia Health - The Globe and Mail
Privia Health Group, Inc. (NASDAQ:PRVA) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Privia Health Group, Inc. (NASDAQ:PRVA) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
Privia Health Group Adjusts Valuation Amid Evolving Market Dynamics in Insurance Sector - MarketsMojo
3 Healthcare IT Stocks Up More Than 20% in 2025 With More Room to Run - The Globe and Mail
Evolent Health (EVH) Sells ACO Unit, Strengthens Balance Sheet - Finviz
Riverbridge Partners LLC Has $115.38 Million Position in Privia Health Group, Inc. $PRVA - MarketBeat
Signal Recap: Why hedge funds are buying Privia Health Group Inc. stockJuly 2025 Pullbacks & Free Expert Approved Momentum Trade Ideas - Улправда
Why hedge funds are buying Privia Health Group Inc. stock2025 EndofYear Setup & Risk Managed Investment Entry Signals - Улправда
Can Privia Health Group Inc. stock surprise with earnings upsideJuly 2025 Market Mood & Community Verified Watchlist Alerts - DonanımHaber
Is Privia Health Group Inc. stock a dividend growth opportunity2025 Market Sentiment & AI Forecasted Entry and Exit Points - DonanımHaber
Q3 2025 Healthcare Technology Earnings Review: Revenue Beats & Stock PerformanceNews and Statistics - IndexBox
Privia Health Group (NASDAQ:PRVA) CFO Sells $597,891.61 in Stock - Defense World
Analysts Are Bullish on These Healthcare Stocks: Nuvalent (NUVL), Novan (NOVN) - The Globe and Mail
Privia Health finalizes acquisition of ACO business - MSN
Privia Health Group (NASDAQ:PRVA) Director Matthew Shawn Morris Sells 13,647 Shares - MarketBeat
[Form 4] Privia Health Group, Inc. Insider Trading Activity - Stock Titan
Here's Why We Think Privia Health Group (NASDAQ:PRVA) Is Well Worth Watching - Yahoo Finance
Privia Health Group, Inc.'s (NASDAQ:PRVA) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum? - simplywall.st
1 Cash-Heavy Stock for Long-Term Investors and 2 We Turn Down - Finviz
Bellevue Group AG Trims Stock Position in Privia Health Group, Inc. $PRVA - MarketBeat
Analysts Offer Insights on Healthcare Companies: Hinge Health, Inc. Class A (HNGE), Exelixis (EXEL) and Natera (NTRA) - The Globe and Mail
3 Reasons to Sell PRVA and 1 Stock to Buy Instead - Yahoo Finance
(PRVA) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com
Privia Health Group (NASDAQ:PRVA) vs. Precipio (NASDAQ:PRPO) Critical Contrast - Defense World
Macro Review: Can Privia Health Group Inc stock surprise with earnings upsidePortfolio Return Report & Weekly Sector Rotation Insights - moha.gov.vn
Privia Health completes acquisition of ACO business from Evolent Health By Investing.com - Investing.com Canada
Privia Health Finalizes Acquisition of ACO Business - TipRanks
Privia Health completes acquisition of ACO business from Evolent Health - Investing.com
Financial Comparison: United Treatment Centers (OTCMKTS:POTN) and Privia Health Group (NASDAQ:PRVA) - Defense World
Hsbc Holdings PLC Raises Stake in Privia Health Group, Inc. $PRVA - MarketBeat
Schroder Investment Management Group Has $3.09 Million Holdings in Privia Health Group, Inc. $PRVA - MarketBeat
Capital Fund Management S.A. Takes Position in Privia Health Group, Inc. $PRVA - Defense World
Edgestream Partners L.P. Invests $2.21 Million in Privia Health Group, Inc. $PRVA - Defense World
Privia Health Group (NASDAQ:PRVA) Given Overweight Rating at Stephens - MarketBeat
Finanzdaten der Privia Health Group Inc-Aktie (PRVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.88%
1.93%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):